ATE357916T1 - Tiagabine zur behandlung von diabetischer neuropathie - Google Patents
Tiagabine zur behandlung von diabetischer neuropathieInfo
- Publication number
- ATE357916T1 ATE357916T1 AT01986237T AT01986237T ATE357916T1 AT E357916 T1 ATE357916 T1 AT E357916T1 AT 01986237 T AT01986237 T AT 01986237T AT 01986237 T AT01986237 T AT 01986237T AT E357916 T1 ATE357916 T1 AT E357916T1
- Authority
- AT
- Austria
- Prior art keywords
- diabetic neuropathy
- tiagabine
- treatment
- migraine
- butenyl
- Prior art date
Links
- 208000032131 Diabetic Neuropathies Diseases 0.000 title abstract 2
- PBJUNZJWGZTSKL-MRXNPFEDSA-N tiagabine Chemical compound C1=CSC(C(=CCCN2C[C@@H](CCC2)C(O)=O)C2=C(C=CS2)C)=C1C PBJUNZJWGZTSKL-MRXNPFEDSA-N 0.000 title abstract 2
- 229960001918 tiagabine Drugs 0.000 title 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69336100A | 2000-10-20 | 2000-10-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE357916T1 true ATE357916T1 (de) | 2007-04-15 |
Family
ID=24784340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01986237T ATE357916T1 (de) | 2000-10-20 | 2001-10-19 | Tiagabine zur behandlung von diabetischer neuropathie |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1331933B1 (de) |
| JP (1) | JP4387102B2 (de) |
| AT (1) | ATE357916T1 (de) |
| CA (1) | CA2421042C (de) |
| DE (1) | DE60127571T2 (de) |
| ES (1) | ES2284711T3 (de) |
| MX (1) | MXPA03003310A (de) |
| WO (1) | WO2002038144A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1747747B (zh) | 2003-01-06 | 2012-09-05 | 安吉奥开米公司 | 作为穿过血脑屏障的载体的抑酶肽及类似物 |
| US9365634B2 (en) | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
| US8921314B2 (en) | 2008-10-15 | 2014-12-30 | Angiochem, Inc. | Conjugates of GLP-1 agonists and uses thereof |
| US10980892B2 (en) | 2015-06-15 | 2021-04-20 | Angiochem Inc. | Methods for the treatment of leptomeningeal carcinomatosis |
-
2001
- 2001-10-19 ES ES01986237T patent/ES2284711T3/es not_active Expired - Lifetime
- 2001-10-19 WO PCT/US2001/051407 patent/WO2002038144A2/en not_active Ceased
- 2001-10-19 EP EP01986237A patent/EP1331933B1/de not_active Expired - Lifetime
- 2001-10-19 AT AT01986237T patent/ATE357916T1/de not_active IP Right Cessation
- 2001-10-19 JP JP2002540730A patent/JP4387102B2/ja not_active Expired - Fee Related
- 2001-10-19 CA CA2421042A patent/CA2421042C/en not_active Expired - Fee Related
- 2001-10-19 MX MXPA03003310A patent/MXPA03003310A/es active IP Right Grant
- 2001-10-19 DE DE60127571T patent/DE60127571T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2421042C (en) | 2011-07-05 |
| DE60127571T2 (de) | 2008-01-24 |
| CA2421042A1 (en) | 2002-05-16 |
| EP1331933B1 (de) | 2007-03-28 |
| WO2002038144A8 (en) | 2002-07-11 |
| DE60127571D1 (de) | 2007-05-10 |
| JP4387102B2 (ja) | 2009-12-16 |
| EP1331933A2 (de) | 2003-08-06 |
| JP2004513145A (ja) | 2004-04-30 |
| MXPA03003310A (es) | 2003-09-10 |
| WO2002038144A2 (en) | 2002-05-16 |
| ES2284711T3 (es) | 2007-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE450269T1 (de) | Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten | |
| ATE390142T1 (de) | Synergistische zusammensetzung zur behandlung von diabetes mellitus | |
| DE69833971D1 (de) | Verfahren zur behandlung von alzheimerschen krankheit | |
| ATE207352T1 (de) | Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen | |
| DE69905938D1 (de) | Kombination von duloxetin mit nichtsteroid-entzündungshemmern für die behandlung von schmerz | |
| DE60215787D1 (de) | Behandlung von typ ii diabetes mit dipeptidyl-peptidase-iv-hemmern | |
| TR200200205T2 (tr) | MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi | |
| SE0301886D0 (sv) | New use V | |
| NO20060416L (no) | Ny anvendelse I | |
| ES2151599T3 (es) | Acidos hidroxamicos substituidos con arilsulfonamido como inhibidores de matriz metaloproteinasas. | |
| BR0008958A (pt) | Inibidores de reabsorção de monoamina para otratamento de distúrbios do snc | |
| DK1301201T3 (da) | Behandling af glycogenosis type II | |
| ATE395052T1 (de) | Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes | |
| ATE315390T1 (de) | Zyklische polyamine zur behandlung der thrombozytopenie | |
| DE60041753D1 (de) | Arzneimittel zur behandlung von c. pneumoniae infektionen | |
| ES2119094T3 (es) | Inhibicion de la hemorragia uterina disfuncional. | |
| ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
| FR2825273B1 (fr) | Composition pour le traitement des signes cutanes du vieillissement | |
| DE60127571D1 (de) | Tiagabine zur behandlung von diabetischer neuropathie | |
| ATE321045T1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
| SE0004101D0 (sv) | New use | |
| NO970340D0 (no) | Organiske forbindelser | |
| DE60027127D1 (de) | Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen | |
| ATE279924T1 (de) | 3-cyclopropylmethoxy-4-difluormethoxy-n-(3,5- dichlor-pyrid-4-yl)-benzamid zur behandlung von multipler sklerose | |
| SE0301883D0 (sv) | New use II |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |